Delta Investment Management’s Innovator US Equity Ultra Buffer ETF July UJUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$249K Hold
6,500
0.04% 228
2025
Q4
$252K Sell
6,500
-105
-2% -$4.03K 0.04% 234
2025
Q3
$252K Hold
6,605
0.05% 236
2025
Q2
$243K Sell
6,605
-8
-0.1% -$274 0.05% 214
2025
Q1
$222K Sell
6,613
-3,611
-35% -$125K 0.04% 223
2024
Q4
$353K Sell
10,224
-222
-2% -$7.64K 0.07% 171
2024
Q3
$354K Sell
10,446
-3,903
-27% -$129K 0.07% 165
2024
Q2
$467K Sell
14,349
-113,991
-89% -$3.66M 0.1% 119
2024
Q1
$4.09M Sell
128,340
-63,351
-33% -$1.97M 0.93% 22
2023
Q4
$5.81M Sell
191,691
-38,964
-17% -$1.13M 1.44% 19
2023
Q3
$6.51M Buy
+230,655
New +$6.66M 1.8% 14

Other funds holding UJUL

Delta Investment Management's UJUL Position: Q1 2026 in Review

Delta Investment Management held its Innovator US Equity Ultra Buffer ETF July (UJUL) position steady in Q1 2026 at 6,500 shares worth $249K. The position accounts for 0.04% of the portfolio, ranked #228.

Delta Investment Management first reported a position in UJUL in Q3 2023 and has held it in 11 quarters since. The position peaked at $6.51M in Q3 2023. 73 funds tracked by Wall St. Rank hold UJUL as of Q1 2026.

  • Delta Investment Management held 6,500 shares of Innovator US Equity Ultra Buffer ETF July worth $249K as of Q1 2026.
  • Delta Investment Management left its Innovator US Equity Ultra Buffer ETF July share count unchanged in Q1 2026.
  • Innovator US Equity Ultra Buffer ETF July made up 0.04% of Delta Investment Management's portfolio in Q1 2026, its #228 holding.
  • Delta Investment Management first reported a position in Innovator US Equity Ultra Buffer ETF July in Q3 2023 and has held it in 11 quarters since.
  • Delta Investment Management's Innovator US Equity Ultra Buffer ETF July position peaked at $6.51M in Q3 2023.
  • 73 funds tracked by Wall St. Rank held Innovator US Equity Ultra Buffer ETF July as of Q1 2026.

Based on Delta Investment Management's 13F filing for Q1 2026, filed 13 May 2026.